SERPINB9 and cancer: To strengthen the evidence for SERPINB9’s role in maintaining cancer stemness, a limiting dilution assay, the gold standard for assessing the self-renewal capacity of cancer stem cells (CSCs) in vivo, was performed (Fig. 4e, f; Fig. S6a–c).